Morningstar US Small Growth Rating $13.91 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Ratings Stock AnalysisChartRatingsBuy This Stock Morningstar US Small Growth Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MSGR Aggregate RatingModerate Buy 2.62Holdings in MSGR have an aggregate rating of Moderate Buy based on 274 analyst ratings issued in the past year covering 21 companies (90.8% of the portfolio).MSGR Aggregate Price Target$13.91High Prediction$13.91Average Prediction$13.91Low Prediction$13.91Holdings in MSGR have an aggregate price target of $13.91 and a range of $13.91 to $13.91 covering 21 companies (90.8% of the portfolio).MSGR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Morningstar US Small Growth Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 MSGR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.06%VRTXVertex Pharmaceuticals$462.13+1.2%4.346 of 5 stars2.50$509.89 10.3%26Positive NewsUpcoming EarningsShort Interest ↑7.99%SCLXScilex$13.41-0.1%2.082 of 5 stars2.50$455.00 3,293.0%4News CoverageGap Down7.01%ARCTArcturus Therapeutics$12.30+0.7%3.018 of 5 stars3.11$54.00 339.0%9Positive News6.62%ALNYAlnylam Pharmaceuticals$401.80+2.4%3.8528 of 5 stars2.81$392.13 -2.4%26Trending NewsAnalyst Forecast6.44%MRNAModerna$27.60-6.6%4.4704 of 5 stars2.04$46.11 67.1%25Trending NewsEarnings ReportAnalyst ForecastOptions VolumeGap Down6.17%BNTXBioNTech$107.34-0.1%2.7548 of 5 stars2.76$136.58 27.2%17Upcoming EarningsGap Down5.97%SRPTSarepta Therapeutics$15.91-3.1%4.7102 of 5 stars2.10$49.12 208.7%29Trending NewsUpcoming EarningsAnalyst ForecastOptions Volume5.78%PTCTPTC Therapeutics$52.13+0.0%4.4867 of 5 stars2.67$69.38 33.1%15Trending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision4.94%MRVIMaravai LifeSciences$2.22-5.1%3.734 of 5 stars2.25$6.64 199.0%12Gap Down4.29%NTLAIntellia Therapeutics$11.49-1.3%4.5819 of 5 stars2.65$33.37 190.4%20News CoverageUpcoming EarningsGap Down4.24%IONSIonis Pharmaceuticals$43.03+0.1%4.5487 of 5 stars2.86$59.38 38.0%14Trending NewsEarnings ReportAnalyst ForecastInsider Trade3.19%RNAAvidity Biosciences$35.92-2.2%2.7824 of 5 stars3.06$66.35 84.7%17News CoverageUpcoming Earnings3.19%CVACCureVac$5.41+0.4%4.4448 of 5 stars2.20$6.83 26.3%5News CoveragePositive News3.18%ARWRArrowhead Pharmaceuticals$15.93+0.8%3.8252 of 5 stars2.89$43.71 174.4%9News CoverageUpcoming Earnings2.95%ABUSArbutus Biopharma$3.27-0.3%2.1737 of 5 stars3.00$5.50 68.2%4News CoverageUpcoming Earnings2.59%DYNDyne Therapeutics$10.05+2.0%3.5791 of 5 stars3.00$36.25 260.7%17Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.10%SGMOSangamo Therapeutics$0.56+4.6%1.5179 of 5 stars2.67$4.50 701.3%6News CoverageUpcoming Earnings1.84%STOKStoke Therapeutics$12.91+0.5%4.0156 of 5 stars3.29$25.80 99.8%7Upcoming Earnings1.53%HLVXHilleVax$2.04-3.3%1.8457 of 5 stars2.00$2.00 -2.0%1News CoveragePositive News1.52%PRQRProQR Therapeutics$2.08-1.0%2.0875 of 5 stars3.13$8.00 284.6%8Upcoming Earnings1.20%PEPGPepGen$1.32-3.6%2.6556 of 5 stars2.33$7.67 480.8%3Gap Down This page (NYSEARCA:MSGR) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Morningstar US Small Growth Please log in to your account or sign up in order to add this asset to your watchlist. Share Morningstar US Small Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.